Home-BioDuro-Sundia

BioDuro-Sundia

A stellar compliance record following global standards

BioDuro-Sundia, an Advent International portfolio company is a trusted, leading contract research development, manufacturing organization (CRDMO) for over 27 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US and China with more than 3,000 employees and 9 global sites across 6 cities.

Learn more

Fully Integrated CRDMO

One stop shop built to accelerate your timelines

Discovery

Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics

Hit Generation

Lead Optimization

Candidate Selection

Learn more

Drug Substance

Process R&D Scale Up Synthesis DS Manufacturing

Scale Up g → kg

RSMs, Intermediates & API

IND Filing (FDA, NMPA and others)

Learn more

Drug Product

Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing

Solubility Enhancement

Solid Oral Dosage Forms

Clinical & Commercial

Learn more

Platforms

Cutting-edge platforms and integrated solutions for first-in-class and innovative drug discovery, development and manufacturing

Learn more

Discover drugs faster with our comprehensive
in vitro evaluation platform

Bioavailability enhancement

Integrated services under one roof: synthetic chemistry, biology, DMPK, more.

Our one stop shop platform seamlessly
integrates preclinical research services

Find your next hit with the BioDuro-Sundia
fragment screening platform

Tailored engine for small molecular drug discovery
Unlock exponential possibilities screening billions of small molecules

Advanced preclinical models for NASH
Clinical relevance, shortened timelines

Quick collection with vast number
of compounds to speed drug discovery

Delayed, sustained, and custom release

PROTAC

Solution Engine 2.0

Integrated Drug Discovery (IDD)

IND Enabling

Fragment-Based
Drug Discovery (FBDD)

DNA-Encoded Library (DEL)

NASH models

Parallel Synthesis

Modified Release

News & Resources

The latest news about BioDuro-Sundia

Learn more

Company News

BioDuro-Sundia Radioisotope Laboratory Technology Upgrades Accelerate Innovation

Shanghai, November 15, 2023 – Radioisotope assays a microanalytical method that uses radionuclides as tracers to label research objects. Compared with conventional biological sample detection tec

November 15, 2023

Company News

Leadingtac Presents 2023 Best Partner Award to BioDuro-Sundia Chemistry Team

November 10, 2023

Company News

Lynk Pharmaceuticals Presents Long-Term Outstanding Service Award to BioDuro-Sundia Chemistry Team

September 25, 2023

Company News

Congratulate Zhiben Pharma for Receiving China CDE Implied License to Initiate Clinical Trials for Antimicrobial Drug ZB-001

August 01, 2023

Work and careers

Build your career with BioDuro-Sundia

Our customer-oriented, science-driven, flexible, and people-focused culture enables us to provide top-tier integrated service as well as attract and retain talents, ensuring high-quality value delivery.

Learn more